| Date | Time | Source | Headline | Symbol | Company |
| 05/17/2024 | 3:00PM | iHub Newswire | FeaturedMusic Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements | | |
| 05/20/2021 | 7:16AM | InvestorsHub NewsWire | Lexaria's Newest DehydraTECHTM 2.0 Formulation Tested in Study HYPER-A21-2 Demonstrates Its Strongest CBD Absorption..cont | CSE:LXX | Lexaria Bioscience Corp |
| 04/22/2021 | 7:30AM | InvestorsHub NewsWire | Lexaria Commences Human Clinical Hypertension Study | CSE:LXX | Lexaria Bioscience Corp |
| 04/14/2021 | 7:37AM | InvestorsHub NewsWire | Lexaria's DehydraTECHTM Technology Utilized in Amari's "Everyday Calm," Named a Top CBD Product Pick by New Hope Network | CSE:LXX | Lexaria Bioscience Corp |
| 04/06/2021 | 7:16AM | InvestorsHub NewsWire | Lexaria to Evaluate DehydraTECHTM in Multiple New Markets | CSE:LXX | Lexaria Bioscience Corp |
| 03/24/2021 | 8:00AM | InvestorsHub NewsWire | Lexaria Technology Generates Positive Stability Testing for World-Class Ready to Drink CBD Beverages | CSE:LXX | Lexaria Bioscience Corp |
| 03/10/2021 | 11:54AM | InvestorsHub NewsWire | Could DehydraTECH(TM) CBD be Worth $3 Billion a Year to Lexaria? | CSE:LXX | Lexaria Bioscience Corp |
| 01/27/2021 | 8:00AM | InvestorsHub NewsWire | CANNABIS INVESTING - Khiron (KHRNF) & Lexaria (LEXX) with Ted Ohashi | CSE:LXX | Lexaria Bioscience Corp |
| 12/16/2020 | 10:00AM | InvestorsHub NewsWire | CANNABIS INVESTING - Cannabis News, Khiron, & Lexaria Bioscience | CSE:LXX | Lexaria Bioscience Corp |
| 12/01/2020 | 6:41AM | InvestorsHub NewsWire | Lexaria's Patented Technology Significantly Enhances Oral Delivery of Antiviral Drugs | CSE:LXX | Lexaria Bioscience Corp |
| 09/04/2019 | 8:45AM | InvestorWire | Innovative Drug-Delivery Systems Benefit Patients and Businesses | CSE:LXX | Lexaria Bioscience Corp |
| 06/11/2019 | 8:45AM | InvestorWire | Dramatically Improved Delivery Systems Promise More Effective Cannabis Treatments | CSE:LXX | Lexaria Bioscience Corp |
| 05/29/2019 | 8:45AM | InvestorWire | Disruptive CBD Delivery Technology Could Revolutionize World of Cannabis Consumer Products, Edibles | CSE:LXX | Lexaria Bioscience Corp |
| 01/30/2019 | 8:45AM | InvestorWire | Outside Investment, New Technology Support Growing Cannabis Industry | CSE:LXX | Lexaria Bioscience Corp |
| 01/16/2019 | 8:45AM | InvestorWire | Definitive Agreement Marks Milestone for Alternative Nicotine Delivery Options | CSE:LXX | Lexaria Bioscience Corp |
| 11/28/2018 | 8:45AM | InvestorWire | Booming Cannabis Consumables Space Continues to see Product Innovations | CSE:LXX | Lexaria Bioscience Corp |
| 10/22/2018 | 8:45AM | InvestorWire | Canada Leads International Cannabis Boom — and It’s Not About Smoking | CSE:LXX | Lexaria Bioscience Corp |
| 10/04/2018 | 8:45AM | InvestorWire | Intangible Assets Power Growth, Acquisitions in the Pharmaceuticals Sector | CSE:LXX | Lexaria Bioscience Corp |
| 08/15/2018 | 8:45AM | InvestorWire | Big Businesses Look for Healthier Alternatives to Smoking for Drug Delivery | CSE:LXX | Lexaria Bioscience Corp |
| 04/24/2018 | 8:45AM | InvestorWire | Innovative Cannabis Delivery Technology Boosts Discovery, Momentum in Biotech Sectors | CSE:LXX | Lexaria Bioscience Corp |
| 04/03/2018 | 8:45AM | InvestorWire | Cannabis Biotech Booms | CSE:LXX | Lexaria Bioscience Corp |
| 02/06/2018 | 8:45AM | InvestorWire | Cannabis Deals Cross the Billion-Dollar Mark in Canada | CSE:LXX | Lexaria Bioscience Corp |
| 01/09/2018 | 8:45AM | InvestorWire | Intriguing Research into Pathways to Limit Nicotine, Quit Cigarette Use | CSE:LXX | Lexaria Bioscience Corp |
| 11/09/2017 | 10:12AM | InvestorsHub NewsWire | Lexaria Bioscience Files Innovative New Patent Application | CSE:LXX | Lexaria Bioscience Corp |
| 11/02/2017 | 8:45AM | InvestorWire | Bioabsorption Breakthrough Shows Promise for Tobacco, Cannabinoids, Medication | CSE:LXX | Lexaria Bioscience Corp |
| 11/01/2017 | 9:32AM | InvestorsHub NewsWire | Lexaria Bioscience Receives Groundbreaking U.S. Patent Allowance for its DehydraTECHTM Delivery of THC, NSAIDs, and Nicotine ... | CSE:LXX | Lexaria Bioscience Corp |
| 09/19/2017 | 8:45AM | InvestorWire | Advances in Drug Delivery Hold the Promise of Reducing Inevitable Side Effects | CSE:LXX | Lexaria Bioscience Corp |
| 09/06/2017 | 8:45AM | InvestorWire | Landmark M&A Deals Continue to Shape Big Pharma | CSE:LXX | Lexaria Bioscience Corp |
| 08/16/2017 | 8:45AM | InvestorWire | FDA Proposal Puts Spotlight on Big Tobacco and Industry Innovators | CSE:LXX | Lexaria Bioscience Corp |
| 07/27/2017 | 8:45AM | InvestorWire | Biotech Players Lead the Growth Charge in the Legal Cannabis Market | CSE:LXX | Lexaria Bioscience Corp |